Jazz Pharmaceuticals
JAZZ
#2009
Rank
โ‚ฌ8.52 B
Marketcap
140,26ย โ‚ฌ
Share price
1.58%
Change (1 day)
16.67%
Change (1 year)

Market capitalization of Jazz Pharmaceuticals (JAZZ)

Market cap: โ‚ฌ8.52 Billion

As of January 2026 Jazz Pharmaceuticals has a market cap of โ‚ฌ8.52 Billion. This makes Jazz Pharmaceuticals the world's 2009th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jazz Pharmaceuticals from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ8.52 B-3.35%
2025โ‚ฌ8.81 B21.82%
2024โ‚ฌ7.23 B3.34%
2023โ‚ฌ7.00 B-25.09%
2022โ‚ฌ9.35 B35.24%
2021โ‚ฌ6.91 B-8.26%
2020โ‚ฌ7.53 B0.75%
2019โ‚ฌ7.48 B20.06%
2018โ‚ฌ6.23 B-7.38%
2017โ‚ฌ6.72 B8.37%
2016โ‚ฌ6.20 B-21.23%
2015โ‚ฌ7.88 B-3.47%
2014โ‚ฌ8.16 B53.98%
2013โ‚ฌ5.30 B127.02%
2012โ‚ฌ2.33 B86.24%
2011โ‚ฌ1.25 B112.11%
2010โ‚ฌ0.59 B243.92%
2009โ‚ฌ0.17 B407.2%
2008โ‚ฌ33.89 M-86.29%
2007โ‚ฌ0.24 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Jazz Pharmaceuticals was reported to be:

โ‚ฌ8.52 Billion
by Nasdaq info icon info icon
โ‚ฌ8.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Endo International
ENDPQ
โ‚ฌ0.12 M-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
โ‚ฌ30.97 B 263.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ233.18 B 2,636.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ32.23 B 278.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel